Polypharmacological network

A polypharmacological network refers to the complex web of interactions between one or more drugs and multiple biological targets, such as receptors, enzymes, and transporters (Hopkins, 2008, Nature Chemical Biology). Unlike the traditional 'one drug, one target' paradigm, polypharmacology recognizes that many effective medications achieve their therapeutic results by modulating several nodes within a biological pathway or across different systems simultaneously (Reddy & Zhang, 2013, Expert Review of Clinical Pharmacology). This approach is particularly relevant for complex, multifactorial diseases like cancer, diabetes, and central nervous system disorders, where redundant pathways often allow the disease to bypass single-target inhibition (Anighoro et al., 2014, Journal of Medicinal Chemistry). While polypharmacology can enhance efficacy and reduce the development of drug resistance, it also increases the risk of off-target adverse effects due to the broad interaction profile of the compounds involved. Modern drug discovery increasingly utilizes computational modeling and systems biology to design drugs that intentionally hit specific polypharmacological networks to optimize clinical outcomes (Gujral et al., 2014, PNAS). This paradigm shift acknowledges that the robustness of biological systems often requires a multi-pronged intervention to achieve a meaningful clinical response. Consequently, the study of these networks involves mapping drug-target-disease associations to predict both therapeutic synergy and potential toxicity.

Other names

Network pharmacologyMulti-target pharmacologySystems pharmacologyPolypharmacologyDrug-target interaction network

Simultaneous modulation of multiple distinct molecular targets or signaling pathways to achieve a synergistic therapeutic effect and overcome biological redundancy.